NKGen Biotech Korea Co. Ltd. (182400)
182400 · Health Care · 
Korea
NKGen Biotech Korea Co. Ltd. (182400) is a company in the Health Care sector, based in Korea. The stock is held in 3 ETFs we track. Anyone holding one of these ETFs also owns a small indirect stake in NKGen Biotech Korea.
How many funds hold this stock?
Below-average ETF coverage: 3 of the 95 ETFs we cover hold NKGen Biotech Korea, spread across 2 indices. That puts the stock in more ETFs than 23.2 % of the 4,334 stocks we cover.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is NKGen Biotech Korea in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| SPYI / SPSA | msci-acwi-imi | 0.00 % | €0.00 |
| IS3N | msci-em-imi | 0.00 % | €0.00 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to NKGen Biotech Korea as of the fund's latest holdings list.
How much NKGen Biotech Korea Co. Ltd. overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as NKGen Biotech Korea — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| Sam Chun Dang Pharm. Co. Ltd. | 000250 | 3 | – |
| Daewoong Co. Ltd. | 003090 | 3 | – |
| GC Biopharma Corp. | 006280 | 3 | – |
| NATURECELL Co. Ltd. | 007390 | 3 | – |
| Hanmi Science Co. Ltd | 008930 | 3 | – |
| Hanall Biopharma Co. Ltd. | 009420 | 3 | – |
| Oscotec Inc. | 039200 | 3 | – |
| Celltrion Pharm Inc. | 068760 | 3 | – |
